Concerted interactions between multiple gp41 trimers and the target cell lipidome may be required for HIV-1 entry
暂无分享,去创建一个
Anand Srivastava | Narendra M. Dixit | Prabal K. Maiti | Biswajit Gorai | Anil Kumar Sahoo | N. Dixit | Biswajit Gorai | A. K. Sahoo | Anand Srivastava | P. Maiti | A. Srivastava
[1] D. Graham,et al. Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. , 2003, AIDS research and human retroviruses.
[2] Siewert J Marrink,et al. The mechanism of vesicle fusion as revealed by molecular dynamics simulations. , 2003, Journal of the American Chemical Society.
[3] S. Harrison. Mechanism of Membrane Fusion by Viral Envelope Proteins , 2005, Advances in Virus Research.
[4] Huey W. Huang,et al. Evidence of cholesterol accumulated in high curvature regions: implication to the curvature elastic energy for lipid mixtures. , 2007, Biophysical journal.
[5] J. Enderlein,et al. Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state , 2017, Nature Communications.
[6] Reinhard Lipowsky,et al. Tension-induced fusion of bilayer membranes and vesicles , 2005, Nature materials.
[7] Biswajit Gorai,et al. Prediction and validation of HIV-1 gp41 ecto-transmembrane domain post-fusion trimeric structure using molecular modeling , 2020, Journal of biomolecular structure & dynamics.
[8] Yonathan Kozlovsky,et al. Stalk model of membrane fusion: solution of energy crisis. , 2002, Biophysical journal.
[9] Volker Knecht,et al. Molecular dynamics simulations of lipid vesicle fusion in atomic detail. , 2007, Biophysical journal.
[10] Taehoon Kim,et al. CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..
[11] Helgi I Ingólfsson,et al. CHARMM-GUI Martini Maker for Coarse-Grained Simulations with the Martini Force Field. , 2015, Journal of chemical theory and computation.
[12] D. van der Spoel,et al. GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .
[13] Hans-Georg Kräusslich,et al. The HIV lipidome: a raft with an unusual composition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Lifson,et al. Distribution and three-dimensional structure of AIDS virus envelope spikes , 2006, Nature.
[15] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[16] Annick Thomas,et al. Hydrophobic substitutions in the first residue of the CRAC segment of the gp41 protein of HIV. , 2008, Biochemistry.
[17] B. O’Shaughnessy,et al. SNARE‐mediated membrane fusion is a two‐stage process driven by entropic forces , 2018, FEBS letters.
[18] F. Jensen,et al. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] Eric Hunter,et al. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry , 1998, Nature Medicine.
[20] M. Klein,et al. Effective interaction between small unilamellar vesicles as probed by coarse-grained molecular dynamics simulations , 2014 .
[21] Judith M. White,et al. HIV gp41-Mediated Membrane Fusion Occurs at Edges of Cholesterol-Rich Lipid Domains , 2015, Nature chemical biology.
[22] Reinhard Lipowsky,et al. Solvent-exposed tails as prestalk transition states for membrane fusion at low hydration. , 2010, Journal of the American Chemical Society.
[23] S. Durell,et al. HIV Entry and Envelope Glycoprotein-mediated Fusion* , 2012, The Journal of Biological Chemistry.
[24] Baoshan Zhang,et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.
[25] I. Vattulainen,et al. Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance , 2019, Chemical reviews.
[26] Craig B Wilen,et al. HIV: cell binding and entry. , 2012, Cold Spring Harbor perspectives in medicine.
[27] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[28] A. Trkola,et al. Different Infectivity of HIV-1 Strains Is Linked to Number of Envelope Trimers Required for Entry , 2015, PLoS pathogens.
[29] M. Klein,et al. Coarse-grained molecular dynamics study of membrane fusion: Curvature effects on free energy barriers along the stalk mechanism. , 2015, The Journal of chemical physics.
[30] A. Trkola,et al. The HIV-1 Entry Process: A Stoichiometric View. , 2015, Trends in microbiology.
[31] G. Sapiro,et al. Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.
[32] I. Wilson,et al. Insights into the trimeric HIV-1 envelope glycoprotein structure. , 2015, Trends in biochemical sciences.
[33] W F Drew Bennett,et al. Improved Parameters for the Martini Coarse-Grained Protein Force Field. , 2013, Journal of chemical theory and computation.
[34] Felix Sedlmeier,et al. Hydration repulsion between biomembranes results from an interplay of dehydration and depolarization , 2012, Proceedings of the National Academy of Sciences.
[35] G. Melikyan. Membrane fusion mediated by human immunodeficiency virus envelope glycoprotein. , 2011, Current topics in membranes.
[36] Dennis R Burton,et al. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. , 2016, Annual review of immunology.
[37] Sriram Subramaniam,et al. Electron Tomography of the Contact between T Cells and SIV/HIV-1: Implications for Viral Entry , 2007, PLoS pathogens.
[38] F. Jensen,et al. Lipid composition and fluidity of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[39] David A. Price,et al. Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity , 2005, Antimicrobial Agents and Chemotherapy.
[40] M. Gochin,et al. Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design. , 2011, Current topics in medicinal chemistry.